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Background The incidence and prevalence of autism have dramatically increased
over the last 20 years. Decomposition of autism incidence rates
into age, period and cohort effects disentangle underlying domains
of causal factors linked to time trends. We estimate an age-period-
cohort effect model for autism diagnostic incidence overall and by
level of functioning.
Methods Data are drawn from sequential cohorts of all 6 501 262 individuals
born in California from 1992 to 2003. Autism diagnoses from 1994
to 2005 were ascertained from the California Department of
Development Services Client Development and Evaluation Report.
Results Compared with those born in 1992, each successively younger cohort
has significantly higher odds of an autism diagnosis than the
previous cohort, controlling for age and period effects. For example,
individuals born in 2003 have 16.6 times the odds of an autism diag-
nosis compared with those born in 1992 [95% confidence interval
(CI) 7.8–35.3]. The cohort effect observed in these data is stronger for
high than for low-functioning children with an autism diagnosis.
Discussion Autism incidence in California exhibits a robust and linear positive
cohort effect that is stronger among high-functioning children with
an autism diagnosis. This finding indicates that the primary drivers
of the increases in autism diagnoses must be factors that: (i) have
increased linearly year-to-year; (ii) aggregate in birth cohorts; and
(iii) are stronger among children with higher levels of functioning.
Keywords Autism, cohort effects, time trends, USA
Introduction
The prevalence of autism has increased in many coun-
tries across the last two decades1–9 yet the reasons for
the increase remain highly controversial.10–12 Whereas
a large part of the increase remains unexplained, four
main hypotheses have been supported by empirical
data as contributing to the increase in prevalence:13–15
(i) diagnostic definition (e.g. publication of
DSM-IV16); (ii) diagnostic accretion (i.e. children
with an initial diagnosis of mental retardation acquir-
ing an autism diagnosis) and expansion (i.e. children
with autism at the higher end of the functioning
spectrum being diagnosed with greater
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frequency);13,15 (iii) increased awareness of signs and
symptoms of autism;17 and (iv) individual-level risk
factors that have increased in frequency (e.g. older
parental age at birth18).
Age-period-cohort analyses of data collected over
time can disentangle the time-varying forces shaping
trends over time and help to focus investigations
of underlying aetiology, as each effect implicates a
broad domain of causal factors. In general, age-
period-cohort models decompose variance in trends
over time into those attributable to age-, period-
and cohort-effects. At the individual level, autism
diagnosis is strongly related to child age,19,20 and
substantial evidence indicates that the average age
of diagnosis has decreased in more recently born
cohorts.21 Age effects (i.e. changes in the age struc-
ture of the population or age at diagnostic ascer-
tainment), however, are unlikely to be driving the
increased incidence of autism diagnosis as age-
adjusted rates still show a marked increase over
time.22 Cohort effects can be conceived of as changes
in health status that are confined to or stronger
among particular age groups in particular time peri-
ods.23 Cohort effects could arise in these data through
a number of potential mechanisms. For example, if
the prevalence of a risk factor acting at conception
exhibits change over time (e.g. paternal age), then
each successively younger cohort will be differentially
exposed, manifesting as a cohort effect (e.g. each
successively younger cohort has older fathers).
Alternatively, an exposure introduced into the popu-
lation as a whole could differentially affect autism
incidence depending on age of exposure. This would
also manifest as a cohort effect. In contrast, if period
effects are observed to be the main driver of increased
autism diagnosis, then risk factors which have also
varied across time but have similar effects across
all age groups may be considered as potentially
implicated in the increase in autism. Period effects
can be conceived of as changes in disease status
that affect all age groups simultaneously, and often
coincide with widespread environmental or diagnostic
nosological changes but may also reflect wide-
spread societal changes in some circumstance. The
key in differentiating period from cohort effects is
that if period effects are operative, then the incidence
of autism should increase across all age groups under
study at a particular time, rather than among specific
age groups at a particular time.
Evidence to date is strongly suggestive of powerful
cohort effects in the incidence and prevalence of
autism.21,24,25 For example, data from the Centres
for Disease Control and Prevention funded Autism
and Developmental Disabilities Monitoring (ADDM)
Network indicate a42-fold increase in the prevalence
of autism spectrum disorders among 8-year-olds
in the US born in 1998 compared with 1994
(Morbidity and Mortality Weekly Report26) (with sub-
stantial variation in the size of the increase across
states24) and more recent data indicate that the preva-
lence continues to increase.8 Population-based data
from the California Department of Developmental
Services (DDS) and Denmark indicate consistent in-
creases in the incidence of autism diagnoses across
age for each successively younger birth cohort from
approximately 1990 forward.21,22 This previous work
has not incorporated formal age-period-cohort model-
ling. Thus a quantification of the contribution of age,
period and cohort effects in population-based surveil-
lance data on autism trends is called for in order to
tease apart the effect of cohort from other time-related
trends that vary by period and age.
Finally, previous studies have not examined
age-period-cohort effects in autism diagnostic inci-
dence by level of function at time of diagnosis.
Some have suggested that increases in autism in
recent decades have been primarily restricted to
high-functioning children with autism.27 Functioning
is not a diagnostic designation; here we define func-
tioning in terms of a child’s reported ability in the
domains of communication and social interaction.
If expanded inclusion of high-functioning children
in the diagnostic pool is entirely responsible for
changes in the incidence of autism diagnosis, then
any observed age-period-cohort trends should be
restricted to higher-functioning children with
autism. Thus, examining age-period-cohort trends in
both low-functioning and high-functioning children
with autism provides a robust and innovative
method to examine effects of diagnostic expansion.
The present study utilized a population-registry of
all California births and all diagnoses of autism
registered with the California DDS in order to com-
prehensively characterize age, period and cohort
effects in autism diagnostic incidence from 1994 to
2005, covering cohorts born from 1992 to 2003.
Our main aim was to analyse age-period-cohort
trends in the diagnosis of autism. Additionally, we
examined age-period-cohort models for low- and
high-functioning children with autism.
Methods
Data source
We utilize data on all 6 501 262 individuals born in
California from 1992 to 2003, the cohorts for which
we currently have information available. Data were
drawn from California birth records as well as
Client Development and Evaluation Report (CDER)
records from the DDS, an agency coordinating
diagnoses, services and support for individuals with
developmental disabilities living in California. We
matched DDS records on 21 093 individuals with an
ICD-9 diagnosis of autism born in California between
1992 and 2003 to their California birth records using
probabilistic and deterministic matching algorithms
based on first, middle and last name, birth date,
race, zip code at birth and sex. Further information
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on matching procedures and details of the data can
be found elsewhere.13,19 Incidence rate per 10 000
person-years was determined by creating person-time
for each respondent: individuals were at risk for a
diagnosis each year from age 2 to age 12-years (diag-
noses before age 2 or after age 12 are rare19) until an
autism diagnosis was received. Four individuals
received a diagnosis before age 2 years and were
excluded. Thus, each individual in the data set had a
maximum of 10 points of data, one for each year in
which they were at risk of receiving an autism diagno-
sis. Once an individual received an autism diagnosis,
they no longer contributed person-time. Subsequent
evaluations were not considered in this analysis.
The final analysis included 43 693 205 time points.
Measures
Autism diagnosis
In California the DDS system is responsible for coor-
dinating diagnoses, services and support for persons
with developmental disabilities including autism.
The DDS provides services to patients with full
syndrome autism, but not to those with other spec-
trum disorders or pervasive developmental disorders
unless they have another qualifying condition or
substantial disability. The vast majority of persons
with autism in California are enrolled with the DDS,
making it the largest administrative source of data on
autism diagnoses.14 Autism diagnoses were ascer-
tained by extraction of DDS records for all clients
with a CDER on file between 1994 and 2005.
Trained diagnosticians screened each potential client
upon entry into the system and CDER records were
updated after annual evaluations.
Functioning
As in our previous studies,17 we derived a ‘function-
ing’ score from a global index of function on two
dimensions relevant to autism: social interaction,
and communication and language, both recorded on
the CDER at the time of intake. These scores were
created from evaluations by developmental specialists
based on observation and caregiver reports. These
evaluations are designed to allocate services, and in
the process of the evaluation, developmental special-
ists record scores on structured assessment forms
regarding social interaction, communication and
language. Social interaction functioning was based
on five items [internal consistency–reliability (a)
from 0.85 to 0.86 by birth cohort], and communica-
tion functioning was based on three items (a from
0.77 to 0.84 by birth cohort). These dimensions were
equally weighted and normalized within age groups.
We created cutpoints based on upper and lower
quintiles of the distributions within our data. For
the purpose of the present study, those above the
age-standardized 80th percentile (using the 1992
cohort deciles as the referent) were considered
high-functioning, those in the 20–79th percentile
were considered mid-functioning and those below
the 20th percentile were considered low-functioning.
Note that this is relative to other included subjects.
As such, ‘high-’ and ‘low-’ functioning are neither
diagnostic definitions nor were they designations
used explicitly in the allocation of services.
Sensitivity analyses using a range of alternative
cutpoints did not change the results.
Statistical methods
Graphical analysis
We began our assessment of age, period and cohort
effects by thorough examination of incidence rates by
graphical analysis. This informs not only the overall
assessment of age, period and cohort effects, but also
the type of and specifications for statistical modelling.
Statistical model
The best practice for statistical modelling of age,
period and cohort effects has been a source of
scientific and biostatistical debate for over four dec-
ades.23,28–30 Briefly, because age, period and cohort are
linearly related (Cohort¼PeriodAge), simultaneous
consideration of the linear effects of the three vari-
ables in a statistical model results in a non-identified
regression matrix in a least squares framework. When
considering all possible age-period-cohort methods,
the constraint-based approach31 required minimally
restrictive assumptions and provided the best theoret-
ical fit for this research question. We constrained the
model such that the incidence of autism was constant
after age 8 years, based on data indicating this to be
the case (see Figure 1). Birth cohort and period were
unconstrained.
Our constraint-based age-period-cohort model was
a generalized linear model with a logit link function,
in which autism diagnosis was the outcome and
age, period and cohort were categorical predictors. All
models used generalized estimating equations to adjust
standard errors for repeated measures (multiple years
for each child) with an auto-regressive correlation
matrix specification. We tested each of the final
models (overall, and by functioning) for goodness-of-fit
using the Barnhart & Williamson approach.32
Sensitivity analyses were run changing the reference
groups in all categories to determine whether results
were dependent on specific reference groups used; no
changes in interpretation were detected.
Results
Graphical description of age, period and
cohort trends
Age-, period- and cohort-specific incidence rates per
10 000 person-years of observation are shown in
Figure 1. As data were sparse for the 2003 cohort,
we present results for the 1992 to 2002 cohorts
only. By age, autism diagnostic incidence peaks at
age 3 (11 per 10 000 person-years), decreases
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throughout early childhood and remains stably low
after age 7 (1 per 10 000 person-years). By period,
no appreciable trend emerges; the rate is relatively
constant at 4 per 10 000 person-years, save for a
change to 3 per 10 000 person-years in 1999. After
1996, rates remain stable, save for increases from 4
per 10 000 person-years in 2001 to 5 per 100 000
person-years in 2002 and 2004. By cohort, the inci-
dence of autism diagnosis consistently increases with
each successively younger birth cohort.
The flat period graph reflects dual forces simultan-
eously operating; whereas the number of diagnoses
substantially increases in the later years, reflecting
the increasing rate among younger birth cohorts, the
amount of person-time in the denominator also in-
creases over time, as older age groups with individuals
less likely to receive a new diagnosis continue to
contribute person-time. In summary, the combination
of increasing numbers of children with autism due to
younger cohorts with increasing person-time due to
older children still contributing person-time renders
a relatively flat graph indicative of a lack of substan-
tial period effects.
Figure 2 shows the age-specific incidence of autism
by birth cohort. For illustrative purposes, we show
every other birth cohort in the data. As shown, the
incidence increases regardless of age for each progres-
sively younger cohort, especially among those aged
3–6 years.
Statistical age-period-cohort model
As expected, controlling for period and cohort, age
remains strongly related to the odds of autism diag-
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Figure 1 Incidence of autism diagnosis by age, time period and birth cohort in California among those born 1992–2003
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for example, those aged 3 have 37 times the odds of
diagnosis of those aged 2 years [95% confidence inter-
val (CI) 31.7–43.9]. Results for period and cohort
effects are shown in Table 1. We observe a significant
effect of period; controlling for age and birth cohort,
those observed in 1995 have 3.75 times the odds of an
autism diagnosis compared with those observed in
1994 (95% CI 2.4–5.9); after 1995, the period effect
in autism diagnoses is mostly stable. We observe
evidence for a strong and mostly linear cohort effect
that is large in magnitude and statistically significant.
Compared with those born in 1992, each successively
younger cohort has significantly higher odds of an
autism diagnosis, and odds ratios (OR) increase
monotonically across cohorts compared with the
1992 cohort.
Shown in Figure 3 is the predicted probability of an
autism diagnosis based on the age-period-cohort
model for three ages, periods and birth cohorts.
This figure provides a visual representation of the
contribution of all three effects to the incidence of
autism diagnosis based on the model. By isolating
each component, we can see the effect of birth
cohort controlling for age and period; the effect of
period controlling for age and birth cohort; etc.
For example, the six columns aggregated under
‘Calendar Year 2005’ show the predicted probability
of autism for 3- to 5-year-olds in the 1992 and 2005
birth cohorts, holding period at the 2005 estimate
(whereas it is impossible for 3- to 5-year-olds born
in 1992 or 2005 to be actually observed in 2005, we
set it to the 2005 effect, thus, the conditions that
were present in 2005 as predicted by the model).
A hypothetical group of 3-year-olds born in 1992
have a predicted incidence of 1.2 per 10 000 person-
years, holding the estimate for period effect at its
2005 level. A hypothetical group of 3-year-olds born
in 2000 have a predicted incidence of 6.8 per 10 000
person-years, again holding the period effect constant
at its 2005 level. This is indicative of the strong cohort
effect in these data.
Age, period and cohort effects by
functioning
Figure 4 presents the OR for incidence per 10 000
person-years by cohort in three groups based on the
age-period-cohort model: those with high-functioning
autism compared with no diagnosis and those with
low-functioning autism compared with no diagnosis.
The cohort-specific increase in incidence is strongest
among high-functioning children with autism. The
odds of diagnosis with high-functioning autism
among those in the 2002 cohort are 14.6 times that
of the 1992 cohort (95% CI 8.50–25.10). The odds of
diagnosis of low-functioning autism among those in
the 2002 cohort are 3.99 times that of the 1992 cohort
(95% CI 2.31–6.89).
Discussion
We found evidence of a significant birth cohort
effect in the incidence of autism diagnoses in
California from 1994 to 2005 that is stronger for
high-functioning children with autism. This finding
indicates that the primary drivers of the increases in
autism diagnoses are factors that: (i) have increased
linearly year-to-year; (ii) aggregate in birth cohorts;
and (iii) affect those with higher levels of functioning
to a greater degree than those with lower levels of
functioning. Although age-period-cohort models do
not test specific hypotheses about underlying mech-
anisms through which trends arise,23 they do provide
a useful lens through which to evaluate these hypoth-
eses. To be consistent with our findings, a hypothe-
sized mechanism should predict a linear increase over
time in successive birth cohorts and a stronger time
Table 1 Period and cohort effectsa in the incidence of




























aTable based on a constraint-based GEE regression model
simultaneously controlled for age, period and cohort categories.
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trend for high than for low-functioning children
with an autism diagnosis.
For example, one hypothesis for the increased inci-
dence of autism is that increasing social awareness is
driving the trends. If increasing awareness of autism
(or its impact on diagnosis) were increasing linearly
over time, and were concentrated on children of a



























Figure 4 Cohort effects in autism diagnosis in California from 1994 to 2005 by child’s functioning (functioning defined by
a global index on two dimensions relevant to autism: social interaction, and communication and language, both recorded
on the CDER diagnostic and evaluation instrument at the time of intake. Those above the 80th percentile were considered
high-functioning children with autism, those in the 20th to 79th percentile were considered mid-functioning, and those
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Figure 3 Predicted diagnosis of autism per 1000 person-years by age, period and cohort. Predicted incidence based on
age-period-cohort model shown in Table 1
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manifest as a cohort effect, similar to what we
observed. In addition, to be consistent with our find-
ings, increasing awareness must have been stronger
for high than for low-functioning children with
autism at that age. On the other hand, if increasing
social awareness were gradually diffusing and being
applied across the range of ages (mainly 2–8 years)
when children are diagnosed with autism, it should
have been manifest as a period effect. In each succes-
sive calendar year we would see an increase in
diagnoses across this range of ages (i.e. each year,
parents would be more likely to consider whether
their 2- to 8-year-old children may have autism, and
clinicians more likely to refer them to services for
evaluation of autism diagnosis). However, this pattern
is not consistent with our data. These alternative pro-
cesses for increasing social awareness can be empiric-
ally tested, in order to better evaluate the degree to
which increasing social awareness could be driving
the time trend in autism diagnoses.
As a second example, the hypothesis that childhood
vaccines are main drivers of increasing autism
incidence could be examined through this lens.
Vaccination aggregates by birth cohort. Vaccination
patterns have not, however, increased linearly
year-to-year in California. In our view, this makes it
unlikely that vaccination could have produced the
cohort effect observed here.
We note too that a hypothesized confluence of
factors could be evaluated through this lens.
Consider the confluence of increasing social aware-
ness, changes in diagnostic practice and changes in
incidence related to family structure (e.g. parental
age at birth of first child has been increasing33). If
these factors are concentrated in children of a specific
age, the confluence could produce a cohort effect. One
could still observe a cohort effect if the different com-
ponents within such a confluence of factors had a
somewhat different impact at different time points
(e.g. more complete ascertainment affecting increas-
ing incidence in early cohorts, and diagnostic expan-
sion affecting rates of diagnosis in later cohorts).
Although we observe evidence of a small period
effect in our model, with an increase in population
incidence across age coinciding with the publication
of DSM-IV in 1994, it is likely that this is a methodo-
logical artefact. Due to the structure of the data, we
only have information on 2-year-old children in 1994;
in 1995, 3-year-olds are added to the data. As the
incidence of autism diagnosis is low among
2-year-olds and relatively high among 3-year-olds, a
heightened incidence of autism in 1995 in the popu-
lation is likely a reflection of adding 3-year-olds to
the data. Thus we caution against overinterpretation
of the observed period effect from 1994 to 1995.
The lack of period effects could reflect the relatively
constrained age range over which autism diagnoses
typically occur. Although changes in diagnostic prac-
tice could be plausible drivers of a potential period
effect, these changes are likely to affect those in spe-
cific age groups more than others, in which case
changes in diagnostic criteria would manifest as a
cohort effect. Overall, given that environmental fac-
tors would need to have the same effect on autism
diagnoses among children of all ages in order for a
period effect to explain the increases in autism inci-
dence, our findings indicating the lack of substantial
period effects correspond to the developmental
epidemiology of autism.
The present study is limited by a number of factors.
Age-period-cohort models are often criticized because
the additional constraint necessary in order to esti-
mate a model renders results prone to bias.29 These
criticisms are valid when age-period-cohort models
are estimated without background information, prior
hypotheses and close examination of the research
guiding the choice and specification of the statistical
model. For these data we carefully examined the
graphical trends in the data, estimated models with
varying assumptions and ultimately chose the model-
ling strategy that best corresponded to our theory
about mechanisms in these data and the observable
graphical trends with the minimal number of iden-
tifying assumptions. As in all statistical models,
however, our assumptions are unverifiable.
These results should also be reviewed with the limi-
tations of California administrative data in mind.
Whereas these data represent diagnoses from 21 re-
gional centres with similar distributions of function-
ing scores in all centres, the distribution of
functioning has changed over time as children diag-
nosed with autism are increasingly likely to have
higher-functioning scores. Only children with diag-
noses of autism or substantial functional impairment
are served by the California system, thus children
with autism spectrum disorder on the higher end of
the functioning spectrum may be missed in these
data. However, we note that the average levels of
social and verbal functioning as reported at first as-
sessment have substantially increased across cohorts
in these data, as demonstrated in our results.
Nevertheless, these results can only be generalized
to trends over time in autism rather than autism spec-
trum disorders more generally. Other limitations in-
clude use of birth records, which may have coding
errors. However, date of birth is not typically recorded
inaccurately, and any errors are assumed to be
non-differential in nature. Next, because these data
are linked with birth certificate records, individuals
who are born in California but receive an autism diag-
nosis in another state are misclassified as not having
autism in these data. This misclassification would
affect estimates to the extent that migration patterns
out of California have changed over time in ways that
are associated with autism diagnosis. Whereas
out-migration has increased in California, the rich
services provided in California to children with
autism give little ground to suspect that out-migration
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from California is related to autism diagnosis. Finally,
we cannot separate changes in referral patterns and
practices from changes in prevalence in these data, as
only children with autism that came to the attention
of the California DDS are included in these data.
These results have significant implications for
autism research. This research area has been particu-
larly controversial, with a number of factors posited
to affect the observed increase including changes
in diagnostic practice, younger age at diagnosis and
heightened awareness.12,16 Our data do not support
younger age at diagnosis as the driver of increased
incidence, but are consistent with changes in diagnos-
tic practice and heightened awareness as potentially
viable explanations for the increase in autism diag-
noses. We observe a weak period effect compared
with the strong and linear cohort effect, suggesting
that broad environmental factors that have equal
effects across age cannot explain the increase in
autism diagnosis. Further research into possible fac-
tors that increase linearly over time by birth cohort
and are particularly salient for high-functioning
children with autism should be pursued in further
autism research.
Supplementary Data
Supplementary Data are available at IJE online.
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KEY MESSAGES
 Risk of an autism diagnosis increased in each successively younger birth cohort from 1992 to 2003
independently of age and period effects.
 No appreciable period effects are found for autism diagnoses from 1992 to 2003.
 Cohort effects are more pronounced among children who display higher social and language
functioning.
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